Development and validation of a potency assay matrix for optimized and consistent manufacture of clinical mesenchymal stem/stromal cells.
Saved in:
| Title: | Development and validation of a potency assay matrix for optimized and consistent manufacture of clinical mesenchymal stem/stromal cells. |
|---|---|
| Authors: | Niekamp P; Ossium Health, Inc., Indianapolis, IN, United States., Gu D; Ossium Health, Inc., Indianapolis, IN, United States., Jiang J; Ossium Health, Inc., Indianapolis, IN, United States., Woods EJ; Ossium Health, Inc., Indianapolis, IN, United States., Johnstone BH; Ossium Health, Inc., Indianapolis, IN, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Feb 19; Vol. 17, pp. 1725191. Date of Electronic Publication: 2026 Feb 19 (Print Publication: 2026). |
| Publication Type: | Journal Article; Validation Study |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1725191 |
